Cargando…
Dual-mode US/MRI nanoparticles delivering siRNA and Pt(iv) for ovarian cancer treatment
As known to all, ovarian cancer ranks the most lethal of the gynecological malignancies. The antitumor drugs based on platinum are first-line chemotherapy drugs for ovarian cancer. However, their therapeutic efficiency is severely limited owing to dose-limiting toxicities of platinum. New theranosti...
Autores principales: | Zhang, Yanhua, Huang, Hui, Fu, Hao, Zhao, Meng, Wu, Zhihua, Dong, Yang, Li, He, Duan, Yourong, Sun, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073344/ https://www.ncbi.nlm.nih.gov/pubmed/35529112 http://dx.doi.org/10.1039/c9ra03681d |
Ejemplares similares
-
GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer
por: Huang, Hui, et al.
Publicado: (2019) -
Retrovirus-delivered siRNA
por: Devroe, Eric, et al.
Publicado: (2002) -
Plasma polymerized nanoparticles effectively deliver dual siRNA and drug therapy in vivo
por: Michael, Praveesuda, et al.
Publicado: (2020) -
Preparation and Preliminary Evaluation of Dual-functional Nanoparticles for MRI and siRNA Delivery
por: Sun, Jingxin, et al.
Publicado: (2021) -
Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors
por: Gao, Pei, et al.
Publicado: (2015)